Live Breaking News & Updates on Jimmy Jin

Stay updated with breaking news from Jimmy jin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bridge Biotherapeutics Releases Updated Preclinical Data for BBT-207 at the AACR Annual Meeting


New preclinical data validate anti-tumor efficacy and intracranial activity of the drug candidate Bridge submitted an IND application to the U.S. Food and Drug Administration in March, and expects to initiate the first-in-human study of BBT-207 this year SEONGNAM, South Korea and CAMBRIDGE, Mass., April 19, 2023 /PRNewswire/ Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in. ....

United Kingdom , United States , South Korea , Kyonggi Do , Republic Of Korea , Jimmy Jin , American Association For Cancer Research , Drug Administration , Biotherapeutics Inc , Bridge Biotherapeutics Inc , American Association , Cancer Research , Investigational New Drug Application , Epidermal Growth , Factor Receptor , Tyrosine Kinase Inhibitor , With Broad Spectrum Activity , Molecular Therapeutics , Tyrosine Kinase , Phosphatase Inhibitors ,